Skip to main content
ConductScienceScienceDex

Anna Pasternak

NIH Rank #3160
Unclaimed recordClaim profile
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 80112299Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2025 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2025

Linked Award Amount
$3.1M
Full award amounts, FY2025
Award Records
1
Records listing this PI
Award-Linked Rank
#3,160
By linked amount among FY2025 PIs
Earliest Year Loaded
2025
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Anna Pasternak. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Anna Pasternak as a PI. Multi-PI records show the full award amount for context.

  • 1UG3DA064392-01UG3
    Clinical Development of SBS-147: First-in-class Oral Arylepoxamide Agonist for Pain
    Sparian Biosciences, Inc.
    $3.1M
    award amount

Award organization

Organizations that administered FY2025 awards listing Anna Pasternak as a PI.

FY2025 award administered by Sparian Biosciences, Inc. (NY).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2025
    First NIH Award
    Sparian Biosciences, Inc.
  2. 2025
    $500K Cumulative Funding
  3. 2025
    $1M Cumulative Funding
  4. 2025
    $2M Cumulative Funding
  5. 2025
    Entered Top 50% Nationally
    Ranked #3160
  6. 2025
    Entered Top 25% Nationally
    Ranked #3160
  7. 2026
    $5M Cumulative Funding
  8. 2026
    Entered Top 10% Nationally
    Ranked #1052

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Anna Pasternak.

Judy Ashworth
Sparian Biosciences, Inc.
2
shared awards

Explore further

Find collaborators for Anna Pasternak

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →